Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Drugs in Dermatology : JDD|January 11, 2024
Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne VulgarisLawrence F Eichenfield, Linda Stein Gold, Jenny Han, et al.
British Journal of Clinical Pharmacology|August 14, 2012
Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjectsBörje Darpö, Philip Sager, Leigh MacConell, et al.
Vascular Health and Risk Management|May 9, 2012
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysisJulia A Gaebler, Gerardo Soto-Campos, Peter Alperin, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2023
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne VulgarisAdelaide Hebert, Lawrence Eichenfield, Diane Thiboutot, et al.
Neoplasia (New York, N.Y.)|March 4, 2016
Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer CellsYasemin Saygideğer-Kont, Tsion Zewdu Minas, Hayden Jones, et al.
Microcirculation (New York, N.Y. : 1994)|March 23, 2011
A new method for in vivo visualization of vessel remodeling using a near-infrared dyeMarie Billaud, Jeremy A Ross, Mark A Greyson, et al.
Molecular Cancer Therapeutics|September 12, 2015
Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria BoxHaydar Çelik, Sung-Hyeok Hong, Daisy D Colón-López, et al.
Molecular and Cellular Biology|July 8, 2015
Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein LevelHaydar Çelik, Kamal P Sajwan, Saravana P Selvanathan, et al.
Pageof 6